ADHD Drug Vyvanse—Studies

There has been one study in the United States on Vyvanse. This study is as follows:

United States, January 2010: The Journal of the American Academy of Child and Adolescent Psychiatry published a study where researchers evaluated the height, weight and body mass index (BMI) of 281 children ages 6 to 13, for 15 months. They found that, consistent with prior studies of stimulants, treatment with lisdexamfetamine (Vyvanse) lead to statistically significant reductions in expected height, weight, and BMI. Source: Faraone SV, et al., “Effects of lisdexamfetamine dimesylate treatment for ADHD on growth,” Journal of the American Academy of Child and Adolescent Psychiatry, Jan. 2010, 49(1):24-32.

This brochure is a simple guide that documents the dangerous and deadly side effects of the drugs prescribed to millions of men, women and children diagnosed with bogus mental disorders.


Please note: No one should attempt to get off of psychiatric drugs without doctor’s supervision. To help find medical practitioners in your area, click here